Teleflex to Focus on Arrow® Advanced Interventional Radiology Portfolio at EuroPCR
Teleflex to Focus on Arrow® Advanced Interventional Radiology Portfolio at EuroPCR
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) , a leading global provider of medical devices for critical care and surgery, will showcase its interventional radiology solutions at the European Association for Percutaneous Cardiovascular Interventions Course to be held in Paris, France on May 21-24, 2013
During the event, the Company will highlight its diversified range of products for interventional procedures such as transradial access kits, angiographic diagnostic catheters and cath lab focused kink-resistant sheath products. In addition, a range of innovative peripheral angioplasty catheters will be reviewed.
The Company will focus special attention on the unique GPSCath™ Balloon Dilatation Catheter, which is based on the use of the VisioValve™ technology. The GPSCath™ Catheter is a specialty two-in-one device that is intended for dialysis access and peripheral vascular interventions. It allows the physician to conduct angioplasty and inject fluid while maintaining catheter and guidewire position.
A "How To Treat" session is scheduled for Wednesday, May 22nd at 16:45h - 18:15h in EuroPCR Room 241. Prof. Marc R. Sapoval of the Georges Pompidou European Hospital in Paris, Prof. S. Qanadli of the University Hospital of Lausanne, Dr. M. DiPrimio of the Georges Pompidou European Hospital in Paris and Dr. V. Stratiev from Centre Cardiologique du Nord, Paris, will discuss and explore the possibilities of reducing contrast volume and fluoroscopy time with the GPSCath™ balloon dilatation catheter during complex percutaneous transluminal angioplasty procedures.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,700 people worldwide and serves healthcare providers in more than 140 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Arrow, GPSCath and VisioValve are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
or
Martina Teichmann-Zindler
Director Marketing Communications International
+49 (0)7151-406-538
martina.teichmann@teleflex.com
KEYWORDS: United States Europe North America France Pennsylvania
INDUSTRY KEYWORDS:
The article Teleflex to Focus on Arrow® Advanced Interventional Radiology Portfolio at EuroPCR originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
